The value of F-18-fluorodeoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas

This publication has 20 references indexed in Scilit:

• The use of PET in evaluating patients with primary brain tumours: is it useful?
  Journal of Neurology, Neurosurgery & Psychiatry, 1995
• Long-Term Survival in Patients with Malignant Astrocytoma
  Neurosurgery, 1994
• Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults
  Cancer, 1993
• The clinical utility of magnetic resonance imaging in 3-dimensional treatment planning of brain neoplasms
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Identification of early recurrence of primary central nervous system tumors by [¹⁸F]fluorodeoxyglucose positron emission tomography
  Annals of Neurology, 1991
• Intratumoral histologic heterogeneity of gliomas. A quantitative study
  Cancer, 1989
• Positron emission tomography in patients with glioma a predictor of prognosis
  Cancer, 1988
• Positron emission tomography andin vivo measurements of tumour perfusion and oxygen utilisation
  Cancer and Metastasis Reviews, 1987
• Positron Emission Tomography Using [18F] Fluorodeoxyglucose in Brain Tumors A Powerful Diagnostic and Prognostic Tool
  Investigative Radiology, 1987
• Glucose utilization of cerebral gliomas measured by [ ¹⁸ F] fluorodeoxyglucose and positron emission tomography
  Neurology, 1982